Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties

Tim Hempel, Katarina Elez, Nadine Krüger, Lluís Raich, Jonathan H. Shrimp, Olga Danov, Danny Jonigk, Armin Braun, Min Shen, Matthew D. Hall, Stefan Pöhlmann, Markus Hoffmann and Frank Noé

Chem. Sci., 2021, 12, 12600
DOI: 10.1039/D1SC01494C

Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs

Xiaoyu Zhao, Song Luo, Kaifang Huang, Danyang Xiong, John Z. H. Zhang and Lili Duan

Nanoscale, 2021, 13, 19218
DOI: 10.1039/D1NR06313H

A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors

Akihiro Kondo, Kazuhiro J. Fujimoto and Takeshi Yanai

Phys. Chem. Chem. Phys., 2023, 25, 20597
DOI: 10.1039/D3CP01723K

After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives

Hazim Khalifa and Yousef Al Ramahi

IJMS, 2024, 25, 739
DOI: 10.3390/ijms25020739

Opportunities and Regulatory Challenges of Functional Foods and Nutraceuticals During COVID-19 Pandemic

Jobin Jose, Keyidaule Ndang, Madhusoodhana Ballakkuraya Chethana, Chikmagalur Srinath Chinmayi, Khatheeja Afrana, Gopika Gopan, Della Grace Thomas Parambi, Kavita Munjal, Hitesh Chopra, Archana Dhyani and Mohammad Amjad Kamal

CNF, 2024, 20, 1252
DOI: 10.2174/0115734013276165231129102513

Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells

Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, Martin D. Lehner, Georg Seifert and Marcel A. Müller

Front. Pharmacol., 2021, 12
DOI: 10.3389/fphar.2021.757666

The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19

Christiana Mantzourani, Sofia Vasilakaki, Velisaria-Eleni Gerogianni and George Kokotos

Expert Opinion on Drug Discovery, 2022, 17, 231
DOI: 10.1080/17460441.2022.2029843

Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system

Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, Helen Ginn, Elisa Fadda, Gianluca Santoni and Andrea Thorn

Crystallography Reviews, 2024, 30, 74
DOI: 10.1080/0889311X.2024.2363756

Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection

Rama Kashikar, Arun Kumar Kotha, Rakshya Shrestha, Rudragouda Channappanavar and Mahavir Bhupal Chougule

AAPS PharmSciTech, 2025, 26
DOI: 10.1208/s12249-025-03099-3

Lycorine esters exert anti-HCoV-OC43 effect through reversibly acylating cysteine residue in the nsp 12 NiRAN domain

Yuheng Mei, Zhihui Yu, Yue Gong, Runze Meng, Xican Ma, Hu Li, Jiayu Li, Jiandong Jiang, Zonggen Peng, Yinghong Li and Danqing Song

Bioorganic Chemistry, 2025, 154, 108086
DOI: 10.1016/j.bioorg.2024.108086

C-Terminal Analogues of Camostat Retain TMPRSS2 Protease Inhibition: New Synthetic Directions for Antiviral Repurposing of Guanidinium-Based Drugs in Respiratory Infections

Bill T. Ferrara, Elinor P. Thompson, Giovanni N. Roviello and Thomas F. Gale

IJMS, 2025, 26, 6761
DOI: 10.3390/ijms26146761

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

Aurélien F. A. Moumbock, Hoai T. T. Tran, Evelyn Lamy and Stefan Günther

Archiv der Pharmazie, 2023, 356
DOI: 10.1002/ardp.202200371

Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro

Cheng Yang, Dan Li, Shixin Wang, Meijie Xu, Dingfu Wang, Xin Li, Ximing Xu and Chunxia Li

International Journal of Biological Macromolecules, 2023, 227, 316
DOI: 10.1016/j.ijbiomac.2022.11.311

Markov State Models: To Optimize or Not to Optimize

Robert E. Arbon, Yanchen Zhu and Antonia S. J. S. Mey

J. Chem. Theory Comput., 2024, 20, 977
DOI: 10.1021/acs.jctc.3c01134

Relaxed complex scheme and molecular dynamics simulation suggests small molecule inhibitor of human TMPRSS2 for combating COVID-19

Said A. H. Vuai, Marcelina M. Ogedjo, Onoka Isaac, Mtabazi G. Sahini, Hulda S. Swai and Daniel M. Shadrack

Journal of Biomolecular Structure and Dynamics, 2022, 40, 13925
DOI: 10.1080/07391102.2021.1997817

Highlights in TMPRSS2 inhibition mechanism with guanidine derivatives approved drugs for COVID-19 treatment

Wafa Tachoua, Mohamed Kabrine, Mamona Mushtaq, Ahmed Selmi and Zaheer Ul-Haq

Journal of Biomolecular Structure and Dynamics, 2023, 41, 12908
DOI: 10.1080/07391102.2023.2169762

Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo

Nirmal Kumar, Irshad Maajid Taily, Charandeep Singh, Sahil Kumar, Raju S. Rajmani, Debajyoti Chakraborty, Anshul Sharma, Priyanka Singh, Krishan Gopal Thakur, Raghavan Varadarajan, Rajesh P. Ringe, Prabal Banerjee, Indranil Banerjee and Jun Wang

PLoS Pathog, 2023, 19, e1011358
DOI: 10.1371/journal.ppat.1011358

Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system

Philipp Reus, Hadar Guthmann, Nadja Uhlig, Majd Agbaria, Leila Issmail, Valentina Eberlein, Mirjam M. Nordling-David, Doaa Jbara-Agbaria, Sandra Ciesek, Denisa Bojkova, Jindrich Cinatl, Anke Burger-Kentischer, Steffen Rupp, Andrea Zaliani, Thomas Grunwald, Philip Gribbon, Aimo Kannt and Gershon Golomb

Journal of Controlled Release, 2023, 364, 654
DOI: 10.1016/j.jconrel.2023.10.050

Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2

Rohita Rangu, Pandora L Wander, Breanne M Barrow and Sakeneh Zraika

Journal of Molecular Endocrinology, 2022, 69, R63
DOI: 10.1530/JME-21-0282

Mechanistic insights of key host proteins and potential repurposed inhibitors regulating SARS‐CoV‐2 pathway

Debabrata Pramanik, Aiswarya B. Pawar, Sudip Roy and Jayant Kumar Singh

J Comput Chem, 2022, 43, 1237
DOI: 10.1002/jcc.26888

Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

Abdulrahim A. Alzain, Fatima A. Elbadwi and Fatima O. Alsamani

Informatics in Medicine Unlocked, 2022, 29, 100870
DOI: 10.1016/j.imu.2022.100870

In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19

Zohreh Esam, Malihe Akhavan, Maryam Lotfi, Saeed Pourmand and Ahmadreza Bekhradnia

Chem. Pap., 2023, 77, 1129
DOI: 10.1007/s11696-022-02528-y

Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration

Thomas Boehm, Marion Alix, Karin Petroczi, Serhii Vakal, Elisabeth Gludovacz, Nicole Borth, Tiina A. Salminen and Bernd Jilma

The Journal of Pharmacology and Experimental Therapeutics, 2022, 382, 113
DOI: 10.1124/jpet.122.001248

Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat

Yang Zhou, Juhong Wu, Guangpu Xue, Jinyu Li, Longguang Jiang and Mingdong Huang

Biophysical Journal, 2022, 121, 3940
DOI: 10.1016/j.bpj.2022.08.034

The Effectiveness and Safety of Nafamostat Mesylate in the Treatment of COVID-19: a Meta-Analysis

Mian Wei, Toni Li, Siyuan Liu, Yushu Wang, Carolyn Tran and Guangyu Ao

Jpn J Infect Dis, 2024, 77, 182
DOI: 10.7883/yoken.JJID.2023.315

Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview

Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, Achraf El Allali and Driss Cherqaoui

CTMC, 2022, 22, 1776
DOI: 10.2174/1568026622666220726122339

Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins

Tingyu Wang, Yiman Zhai, Hao Xue, Wei Zhou, Yan Ding and Hongguang Nie

Biomolecules, 2023, 13, 578
DOI: 10.3390/biom13040578

Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment

Xiaoqiang Huang, Robin Pearce, Gilbert S. Omenn and Yang Zhang

IJMS, 2021, 22, 7060
DOI: 10.3390/ijms22137060

Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective

Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria P. Costi and Michele Tonelli

J. Med. Chem., 2023, 66, 3664
DOI: 10.1021/acs.jmedchem.2c01229

Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review

María Patricia Hernández-Mitre, Steven Y. C. Tong, Justin T. Denholm, Gregory J. Dore, Asha C. Bowen, Sharon R. Lewin, Balasubramanian Venkatesh, Thomas E. Hills, Zoe McQuilten, David L. Paterson, Susan C. Morpeth and Jason A. Roberts

Clin Pharmacokinet, 2022, 61, 1331
DOI: 10.1007/s40262-022-01170-x

Identification of Embryonic Chicken Proteases Activating Newcastle Disease Virus and Their Roles in the Pathogenicity of Virus Used as In Ovo Vaccine

Helong Feng, Lun Yao, Zhe Zeng, Liren Jiang, Yu Shang, Hongcai Wang, Li Li, Zichen Wang, Xin Wang, Hongchun Yang, Qingqing Zhao, Xiangfei Ren, Tengfei Zhang, Rongrong Zhang, Yunqing Guo, Qin Lu, Qiao Hu, Wenting Zhang, Chan Ding, Huabin Shao, Guofu Cheng, Qingping Luo, Guoyuan Wen and Rebecca Ellis Dutch

J Virol, 2023, 97
DOI: 10.1128/jvi.00324-23

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith, Nadine Krüger, Prerna Arora, Lambert K. Sørensen, Ole S. Søgaard, Jørgen Bo Hasselstrøm, Michael Winkler, Tim Hempel, Lluís Raich, Simon Olsson, Olga Danov, Danny Jonigk, Takashi Yamazoe, Katsura Yamatsuta, Hirotaka Mizuno, Stephan Ludwig, Frank Noé, Mads Kjolby, Armin Braun, Jason M. Sheltzer and Stefan Pöhlmann

EBioMedicine, 2021, 65, 103255
DOI: 10.1016/j.ebiom.2021.103255

Metabolic Activation of PARP as a SARS-CoV-2 Therapeutic Target—Is It a Bait for the Virus or the Best Deal We Could Ever Make with the Virus? Is AMBICA the Potential Cure?

Prasanth Puthanveetil

Biomolecules, 2023, 13, 374
DOI: 10.3390/biom13020374

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment

Lukas Wettstein, Frank Kirchhoff and Jan Münch

IJMS, 2022, 23, 1351
DOI: 10.3390/ijms23031351

Self-Assembled peptide nanofiber-based nanopharmaceutics for the treatment of viral infections

Zeynep Demirsoy, Mehmet Seckin Kesici, Salih Ozcubukcu and Gulcihan Gulseren

Chemical Engineering Journal, 2025, 516, 164066
DOI: 10.1016/j.cej.2025.164066

Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview

Anna Gorący, Jakub Rosik, Bartosz Szostak, Łukasz Ustianowski, Klaudia Ustianowska and Jarosław Gorący

Viruses, 2022, 14, 1092
DOI: 10.3390/v14051092

Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modeling

Hyeon-Cheol Jeong, Yoon-Jee Chae and Kwang-Hee Shin

Transl Clin Pharmacol, 2022, 30, 201
DOI: 10.12793/tcp.2022.30.e20

Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases

Akmaral Assylbekova, Anuar Zhanapiya, Renata Grzywa, Marcin Sienczyk, Christian Schönbach and Timo Burster

Pharmaceuticals, 2022, 15, 500
DOI: 10.3390/ph15050500

Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2

Mohammed R. Shaker, Andrii Slonchak, Bahaa Al-mhanawi, Sean D. Morrison, Julian D. J. Sng, Justin Cooper-White, Alexander A. Khromykh and Ernst J. Wolvetang

Sci. Adv., 2024, 10
DOI: 10.1126/sciadv.adj4735

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors

Aijia Wu, Kunyu Shi, Jiaxing Wang, Ruofei Zhang and Yuxi Wang

European Journal of Medicinal Chemistry, 2024, 263, 115923
DOI: 10.1016/j.ejmech.2023.115923

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

Chris R. Triggle, Devendra Bansal, Hong Ding, Md Mazharul Islam, Elmoubashar Abu Baker Abd Farag, Hamad Abdel Hadi and Ali A. Sultan

Front. Immunol., 2021, 12
DOI: 10.3389/fimmu.2021.631139

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

Judith Grau-Expósito, David Perea, Marina Suppi, Núria Massana, Ander Vergara, Maria José Soler, Benjamin Trinite, Julià Blanco, Javier García-Pérez, José Alcamí, Anna Serrano-Mollar, Joel Rosado, Vicenç Falcó, Meritxell Genescà, Maria J. Buzon and Rudra Channappanavar

PLoS Pathog, 2022, 18, e1010171
DOI: 10.1371/journal.ppat.1010171

Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng

Jeonghui Moon, Younghun Jung, Seokoh Moon, Jaehyeon Hwang, Soomin Kim, Mi Soo Kim, Jeong Hyeon Yoon, Kyeongwon Kim, Youngseo Park, Jae Youl Cho and Dae-Hyuk Kweon

Journal of Ginseng Research, 2023, 47, 123
DOI: 10.1016/j.jgr.2022.07.003

Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2

Sameh S.M. Soliman, Alshaimaa M. Hamoda, Yogendra Nayak, Ahmed Mostafa and Rania Hamdy

European Journal of Medicinal Chemistry, 2024, 276, 116671
DOI: 10.1016/j.ejmech.2024.116671

New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs

Wenyi Zhang, Lecheng Xiao, Dianyang Li, Yuxuan Hu and Wenying Yu

J. Med. Chem., 2024, 67, 11522
DOI: 10.1021/acs.jmedchem.4c00384

Docking-generated multiple ligand poses for bootstrapping bioactivity classifying Machine Learning: Repurposing covalent inhibitors for COVID-19-related TMPRSS2 as case study

Ma'mon M. Hatmal, Omar Abuyaman and Mutasem Taha

Computational and Structural Biotechnology Journal, 2021, 19, 4790
DOI: 10.1016/j.csbj.2021.08.023

Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2

Abdulla Al Mamun, Farjana Akter, Maksud Khan, Sayeda Samina Ahmed, Md. Giash Uddin, Nabila Tabassum Tasfia, Faiyaz Md. Efaz, Md Ackas Ali, Mossammad Umme Chand Sultana and Mohammad A. Halim

Journal of Biomolecular Structure and Dynamics, 2022, 40, 13049
DOI: 10.1080/07391102.2021.1980109

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics

Andrei Veleanu, Maximilian A. Kelch, Chengjin Ye, Melanie Flohr, Alexander Wilhelm, Marek Widera, Luis Martinez-Sobrido, Sandra Ciesek and Tuna Toptan

Viruses, 2022, 14, 2017
DOI: 10.3390/v14092017

DON/DRP‐104 as potent serine protease inhibitors implicated in SARS‐CoV‐2 infection: Comparative binding modes with human TMPRSS2 and novel therapeutic approach

Ernest Oduro‐Kwateng and Mahmoud E. Soliman

J of Cellular Biochemistry, 2024, 125
DOI: 10.1002/jcb.30528

Theoretical Efficacy of Possible Inhibitors of SARS-CoV-2 Cell Recognition and Their Effect on Viral Dynamics in Different Cell Types: Computational Biology and Prediction from in Vitro Experimental Data

Lenin González, Carla Lossada, María Laura Hurtado-León, Francelys V. Fernández-Materán, Edgar Portillo, Joan Vera-Villalobos, Marcos Loroño, J. L. Paz, Laura N. Jeffreys, María Dolores Fernández and Ysaias J. Alvarado

SSRN Journal, 2022
DOI: 10.2139/ssrn.4066277

A Randomized Trial of Nafamostat for Covid-19

Susan C. Morpeth, Balasubramanian Venkatesh, James A. Totterdell, Grace M. McPhee, Robert K. Mahar, Mark Jones, Methma Bandara, Lauren A. Barina, Bhupendra K. Basnet, Asha C. Bowen, Andrew J. Burke, Belinda Cochrane, Justin T. Denholm, Ashesh Dhungana, Gregory J. Dore, Ravindra Dotel, Eamon Duffy, Jack Dummer, Hong Foo, Timothy L. Gilbey, Naomi E. Hammond, Bernard J. Hudson, Vivekanand Jha, Purnima R. Jevaji, Oommen John, Rajesh Joshi, Gagandeep Kang, Baldeep Kaur, Seungtaek Kim, Santa Kumar Das, Jillian S.Y. Lau, Roberta Littleford, Julie A. Marsh, Ian C. Marschner, Gail Matthews, Michael J. Maze, Colin J. McArthur, James D. McFadyen, James H. McMahon, Zoe K. McQuilten, James Molton, Jocelyn M. Mora, Vijaybabu Mudaliar, Vi Nguyen, Matthew V.N. O’Sullivan, Suman Pant, Jaha E. Park, David L. Paterson, David J. Price, Nigel Raymond, Megan A. Rees, James O. Robinson, Benjamin A. Rogers, Wang-Shick Ryu, Joe Sasadeusz, Omar Shum, Thomas L. Snelling, Christine Sommerville, Nanette Trask, Sharon R. Lewin, Thomas E. Hills, Joshua S. Davis, Jason A. Roberts and Steven Y.C. Tong

NEJM Evidence, 2023, 2
DOI: 10.1056/EVIDoa2300132

In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases

Ahmed H. E. Hassan, Selwan M. El-Sayed, Mizuki Yamamoto, Jin Gohda, Takehisa Matsumoto, Mikako Shirouzu, Jun-ichiro Inoue, Yasushi Kawaguchi, Reem M. A. Mansour, Abtin Anvari and Abdelbasset A. Farahat

Viruses, 2023, 15, 1171
DOI: 10.3390/v15051171

GiGs: graph-based integrated Gaussian kernel similarity for virus–drug association prediction

Yixuan Jin, Juanjuan Huang, Xu Sun, Yabo Fang, Jiageng Wu, Jianshi Du, Jiwei Jia and Guoqing Wang

Briefings in Bioinformatics, 2025, 26
DOI: 10.1093/bib/bbaf117

In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity

Kazuhiro J. Fujimoto, Daniel C. F. Hobbs, Miki Umeda, Akihiro Nagata, Rie Yamaguchi, Yoshitaka Sato, Ayato Sato, Kohsuke Ohmatsu, Takashi Ooi, Takeshi Yanai, Hiroshi Kimura and Takayuki Murata

Viruses, 2022, 14, 389
DOI: 10.3390/v14020389

Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177

Niklas Jäger, Markus Hoffmann, Stefan Pöhlmann and Nadine Krüger

Viruses, 2022, 14, 1526
DOI: 10.3390/v14071526

Conformational response to ligand binding of TMPRSS2, a protease involved in SARS‐CoV‐2 infection: Insights through computational modeling

Giorgia Frumenzio, Balasubramanian Chandramouli, Neva Besker, Alessandro Grottesi, Carmine Talarico, Francesco Frigerio, Andrew Emerson and Francesco Musiani

Proteins, 2023, 91, 1288
DOI: 10.1002/prot.26548

Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies

Irene Santamaria-Castro, Rocio Leiva-Rebollo, Sonia Marín-Wong, Jose M. Jimenez-Guardeño, Ana Maria Ortega-Prieto and Stanley Perlman

Microbiol Mol Biol Rev, 2025
DOI: 10.1128/mmbr.00260-24

Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection

Omotayo O. Oyedara, Joseph M. Agbedahunsi, Folasade M. Adeyemi, Alfredo Juárez-Saldivar, Olatomide A. Fadare, Charles O. Adetunji and Gildardo Rivera

Phytomedicine Plus, 2021, 1, 100135
DOI: 10.1016/j.phyplu.2021.100135

Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes

Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Shufeng Liu, Adovi Akue, Mark Kukuruga, Tony T. Wang, Carol D. Weiss, Wei Wang and J.J. Miranda

Microbiol Spectr, 2025, 13
DOI: 10.1128/spectrum.02808-24

Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection

Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, Carina Conzelmann, Yasser Almeida‐Hernández, Markus Hoffmann, Amy Kempf, Inga Nehlmeier, Rishikesh Lotke, Moritz Petersen, Steffen Stenger, Frank Kirchhoff, Daniel Sauter, Stefan Pöhlmann, Elsa Sanchez‐Garcia and Jan Münch

Journal of Medical Virology, 2023, 95
DOI: 10.1002/jmv.28124

TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform

Amanda L. Peiffer, Julie M. Garlick, Yujin Wu, Jesse W. Wotring, Sahil Arora, Alexander S. Harmata, Daniel A. Bochar, Corey J. Stephenson, Matthew B. Soellner, Jonathan Z. Sexton, Charles L. Brooks and Anna K. Mapp

ACS Med. Chem. Lett., 2023, 14, 860
DOI: 10.1021/acsmedchemlett.3c00035

TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate

María Patricia Hernández-Mitre, Susan C. Morpeth, Balasubramanian Venkatesh, Thomas E. Hills, Joshua Davis, Robert K. Mahar, Grace McPhee, Mark Jones, James Totterdell, Steven Y.C. Tong and Jason A. Roberts

Clinical Microbiology and Infection, 2024, 30, 743
DOI: 10.1016/j.cmi.2024.01.029

Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology

Rong Yang, Linhua Liu, Dansheng Jiang, Lei Liu, Huili Yang, Hongling Xu, Meirong Qin, Ping Wang, Jiangyong Gu and Yufeng Xing

J. Chem. Inf. Model., 2023, 63, 3005
DOI: 10.1021/acs.jcim.2c01643

SARS-CoV-2 inhibition through mRNA delivery using engineered extracellular vesicles displaying the spike protein

Yuna Nakagawa, Yoshimasa Kawaguchi, Hisaaki Hirose, Takao Hashiguchi, Joseph Lee, Akitsu Hotta, Jun Kawamoto, Michihito Sasaki, Hirofumi Sawa and Shiroh Futaki

Biomaterials, 2026, 325, 123594
DOI: 10.1016/j.biomaterials.2025.123594

COVID-19: Pathophysiology, Transmission, and Drug Development for Therapeutic Treatment and Vaccination Strategies

Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, Prashant Singh and Ramendra K. Singh

CPD, 2022, 28, 2211
DOI: 10.2174/1381612828666220729093340

Design, synthesis and biological evaluation of novel TMPRSS2-PROTACs with florosubstituted 4-guanidino-N-phenylbenzamide derivative ligands

Hao Yang, Haoran Xu, Xinxin Lin, Zengxuan Cai, Yong Xia, Yu Wang, Zejie Chen, Koutian Zhang, Yanling Wu, Jianwei Wang, Annoor Awadasseid and Wen Zhang

Bioorganic & Medicinal Chemistry, 2024, 116, 117982
DOI: 10.1016/j.bmc.2024.117982

Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor

Katarina Elez, Tim Hempel, Jonathan H. Shrimp, Nicole Moor, Lluís Raich, Cheila Rocha, Robin Winter, Tuan Le, Stefan Pöhlmann, Markus Hoffmann, Matthew D. Hall and Frank Noé

Nat Commun, 2025, 16
DOI: 10.1038/s41467-025-62139-5

Dissecting the Binding Affinity of Anti-SARS-CoV-2 Compounds to Human Transmembrane Protease, Serine 2: A Computational Study

Yue-Hui Shi, Jian-Xin Shen, Yan Tao, Yuan-Ling Xia, Zhi-Bi Zhang, Yun-Xin Fu, Ke-Qin Zhang and Shu-Qun Liu

IJMS, 2025, 26, 587
DOI: 10.3390/ijms26020587

Identification and nanoformulation study of novel 1,2,3-triazole clickamers as potential antivirals against H5N1 and SARS-CoV-2

Hany F. Nour, Ahmed Kandeil, Yaseen A.M.M. Elshaier, Nahla Sameh Tolba, Mohamed Gaballah, Ahmed A. El-Rashedy and Tamer El Malah

Journal of Molecular Structure, 2025, 1339, 142384
DOI: 10.1016/j.molstruc.2025.142384

Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors

C. S. Sharanya, D. Sasikala Wilbee, Shijulal Nelson Sathi and Kathiresan Natarajan

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-65296-7

SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies

Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla and Marco Thomas

Viruses, 2023, 15, 1500
DOI: 10.3390/v15071500

Biophysical Analysis of Potential Inhibitors of SARS-CoV-2 Cell Recognition and Their Effect on Viral Dynamics in Different Cell Types: A Computational Prediction from In Vitro Experimental Data

Lenin González-Paz, Carla Lossada, María Laura Hurtado-León, Joan Vera-Villalobos, José L. Paz, Yovani Marrero-Ponce, Felix Martinez-Rios and Ysaías. J. Alvarado

ACS Omega, 2024, 9, 8923
DOI: 10.1021/acsomega.3c06968

Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor

Suraj Ugrani

Eur Biophys J, 2024, 53, 27
DOI: 10.1007/s00249-023-01695-4

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, Dong hee Chung, André Luiz Lourenço, Dustin Pwee, Anne E. Mayer Bridwell, Markus Hoffmann, Jorine Voss, Partha Karmakar, Nurit P. Azouz, Andrea M. Klingler, Paul W. Rothlauf, Cassandra E. Thompson, Melody Lee, Lidija Klampfer, Christina L. Stallings, Marc E. Rothenberg, Stefan Pöhlmann, Sean P. J. Whelan, Anthony J. O’Donoghue, Charles S. Craik and James W. Janetka

Proc. Natl. Acad. Sci. U.S.A., 2021, 118
DOI: 10.1073/pnas.2108728118

Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening

Yong Cheng, Alex E. Clark, Wonjun Yim, Raina M. Borum, Yu-Ci Chang, Zhicheng Jin, Tengyu He, Aaron F. Carlin and Jesse V. Jokerst

Anal. Chem., 2023, 95, 3789
DOI: 10.1021/acs.analchem.2c04988